Phospho-JAK2 (Y119) Antibody

What is the biological significance of JAK2 Y119 phosphorylation?

Tyrosine 119 (Y119) is a highly conserved residue located in the FERM domain (JH7) of JAK2, representing a major site of autophosphorylation. Y119 phosphorylation plays a critical regulatory role in cytokine receptor signaling. Studies have demonstrated that Y119 phosphorylation occurs rapidly (within 2 minutes) following erythropoietin (Epo) stimulation and persists for at least 60 minutes, showing a comparable temporal pattern to the phosphorylation of the activation loop residues Y1007/1008 .

The functional significance of Y119 phosphorylation is primarily in regulating JAK2's association with cytokine receptors. When phosphorylated, Y119 appears to mediate the dissociation of JAK2 from receptors like the erythropoietin receptor (EpoR), serving as a negative feedback mechanism that attenuates cytokine signaling . This represents a novel mechanism for downregulating cytokine signal transduction.

How does the Y119 residue compare to other phosphorylation sites on JAK2?

Y119 differs significantly from other JAK2 phosphorylation sites in both location and function:

Unlike the well-characterized Y1007/Y1008 residues in the activation loop that directly regulate kinase activity, Y119 in the FERM domain appears to modulate signal duration by affecting receptor-kinase interactions. Phosphopeptide mapping studies have confirmed Y119 as a major autophosphorylation site distinct from nearby residues like Y124 .

Why would researchers specifically study Y119 phosphorylation rather than total JAK2 or other phosphorylation sites?

Researchers focus on Y119 phosphorylation for several compelling reasons:

• Receptor-specificity: Y119 phosphorylation appears to have differential effects depending on receptor context. While it negatively regulates signaling through EpoR, prolactin, and growth hormone receptors, it does not inhibit interferon-γ receptor signaling . This makes it valuable for studying receptor-specific signal transduction mechanisms.

• Regulatory mechanism: Y119 represents a novel regulatory mechanism for JAK2 signaling distinct from the canonical activation loop phosphorylation, providing insight into signal attenuation.

• Disease relevance: Aberrant JAK2 signaling is implicated in myeloproliferative neoplasms (MPNs) and other hematological disorders. Understanding all regulatory mechanisms, including Y119 phosphorylation, may reveal new therapeutic approaches .

• Structure-function relationships: Y119 phosphorylation offers insights into how the FERM domain mediates protein-protein interactions beyond simple receptor binding.

What are the optimal applications for Phospho-JAK2 (Y119) antibodies in research settings?

Phospho-JAK2 (Y119) antibodies have been validated for several applications, with varying levels of optimization:

For most rigorous applications, researchers should consider the following protocol elements:

• For IHC applications: Include phosphopeptide competition controls to confirm specificity, as demonstrated in supplementary data from published studies .

• For temporal studies: Design experiments to capture both early (2 min) and sustained (60 min) phosphorylation events after cytokine stimulation.

• For receptor interaction studies: Combine immunoprecipitation of receptors followed by western blotting for phospho-JAK2 (Y119) .

How should researchers design experiments to study the functional consequences of Y119 phosphorylation?

When investigating the functional significance of Y119 phosphorylation, consider this experimental design framework:

• Mutational analysis approach:

  • Generate Y119F (phospho-deficient) and Y119E (phospho-mimetic) mutants through site-directed mutagenesis

  • Express these constructs in JAK2-deficient cell lines (e.g., JAK2-deficient MEFs)

  • Compare signaling outcomes across multiple readouts: receptor association, JAK2 activation (pY1007/1008), downstream STAT phosphorylation, and biological responses

• Temporal dynamics analysis:

  • Stimulate cells with relevant cytokines (Epo, IFN-γ, etc.)

  • Collect samples at multiple timepoints (0, 2, 5, 15, 30, 60 minutes)

  • Analyze both receptor-associated JAK2 and total cellular JAK2 phosphorylation

  • Compare phosphorylation of Y119 with kinetics of receptor dissociation

• Receptor context comparison:

  • Test Y119 phosphorylation across multiple receptor systems (EpoR, IFN-γR, GHR, PRLR)

  • Compare the functional consequences of Y119 mutations in each receptor context

  • Identify receptor-specific vs. shared mechanisms

Research has demonstrated that Y119F mutants display prolonged JAK2 association with EpoR and enhanced signaling, whereas Y119E mutants are unable to associate with EpoR but retain functionality with IFN-γ receptors .

What controls are essential when working with Phospho-JAK2 (Y119) antibodies?

For rigorous experimental design with phospho-specific antibodies, the following controls are crucial:

• Specificity controls:

  • Y119F mutant JAK2 (negative control for phospho-antibody)

  • Kinase-dead JAK2 mutants (K882R or Y1007F)

  • Peptide competition with phosphorylated and non-phosphorylated peptides

  • JAK2 inhibitor treatment (chemical control)

• Biological context controls:

  • Unstimulated vs. cytokine-stimulated conditions

  • Time course to capture phosphorylation dynamics

  • Multiple cell types to confirm consistency of findings

• Technical controls:

  • Total JAK2 detection (loading control)

  • Additional phosphorylation sites (Y1007/1008) as positive controls for JAK2 activation

  • Global phosphotyrosine detection

Research has validated these controls, demonstrating that Y119 phosphorylation is dependent on JAK2 kinase activity, as neither K882R nor Y1007F mutants show Y119 phosphorylation despite expression .

What are the approaches to quantitatively analyze phospho-JAK2 (Y119) levels in different experimental contexts?

For quantitative analysis of Y119 phosphorylation, researchers should employ:

• Western blot densitometry:

  • Always normalize phospho-Y119 signal to total JAK2 levels

  • Use standard curves with known quantities of recombinant phospho-JAK2

  • Apply statistical analysis across multiple biological replicates (n≥3)

• ELISA-based quantification:

  • Utilize the high sensitivity of ELISA (1:5000 dilution of antibody recommended)

  • Develop standard curves using synthetic phosphopeptides

  • Calculate absolute phosphorylation stoichiometry when possible

• Phosphoproteomics approaches:

  • Employ mass spectrometry to identify and quantify multiple phosphorylation sites simultaneously

  • Use targeted approaches (e.g., selected reaction monitoring) for higher sensitivity

  • Compare relative abundances of different phosphopeptides

• Flow cytometry for single-cell analysis:

  • Adapt protocols similar to those used for other phospho-specific antibodies

  • Ensure proper controls including unstained cells, isotype controls, and viability dyes

  • Analyze population heterogeneity in response to stimulation

For all quantitative approaches, statistical analysis should include appropriate tests for significance and correction for multiple comparisons when analyzing multiple phosphorylation sites or conditions.

How do mutations in Y119 impact other phosphorylation sites in JAK2?

The interdependence between Y119 and other phosphorylation sites reveals complex regulatory networks within JAK2:

When designing studies to examine these relationships, researchers should employ phospho-specific antibodies against multiple sites simultaneously and consider structural biology approaches to understand conformational changes.

What are common technical challenges when working with Phospho-JAK2 (Y119) antibodies and how can they be addressed?

Researchers frequently encounter these challenges when working with phospho-specific antibodies:

• Specificity issues:

  • Problem: Cross-reactivity with other phosphorylated tyrosines in JAK2 or related proteins

  • Solution: Always validate with Y119F mutant controls and peptide competition assays

  • Approach: Pre-absorb antibody with non-phosphorylated peptide to reduce non-specific binding

• Sensitivity limitations:

  • Problem: Low detection of endogenous Y119 phosphorylation

  • Solution: Optimize cell stimulation conditions (time, concentration of cytokines)

  • Approach: Consider enrichment by immunoprecipitation before western blotting

• Phosphatase activity during sample preparation:

  • Problem: Loss of phosphorylation during cell lysis and processing

  • Solution: Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride) in all buffers

  • Approach: Process samples rapidly and maintain at 4°C throughout

• Antibody storage and handling:

  • Problem: Loss of activity due to improper storage

  • Solution: Store at -20°C for long-term; avoid repeated freeze-thaw cycles

  • Approach: For frequent use, aliquot and store at 4°C for up to one month

When troubleshooting, systematically test each variable while maintaining all other conditions constant, and include positive controls (e.g., overexpressed wild-type JAK2 in stimulated cells) in each experiment.

How should sample preparation be optimized for maximum detection of Y119 phosphorylation?

Optimal sample preparation is critical for detecting transient phosphorylation events:

• Cell Stimulation Protocol:

  • Use physiologically relevant concentrations of cytokines (e.g., Epo)

  • Include multiple timepoints (2, 5, 15, 30, 60 minutes) to capture phosphorylation dynamics

  • Consider pre-treating with phosphatase inhibitors or JAK inhibitors as controls

• Lysis Buffer Composition:

  • Base buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40 or Triton X-100

  • Protease inhibitors: PMSF (1 mM), leupeptin (10 μg/ml), aprotinin (10 μg/ml)

  • Critical phosphatase inhibitors: Sodium orthovanadate (1 mM), sodium fluoride (10 mM), β-glycerophosphate (10 mM)

  • Additional component: EDTA (1 mM) to chelate metal ions needed for phosphatase activity

• Processing Steps:

  • Maintain samples at 4°C throughout processing

  • Lyse cells directly in plates by adding ice-cold lysis buffer

  • Clarify lysates by centrifugation (14,000 x g, 15 minutes, 4°C)

  • Determine protein concentration by Bradford or BCA assay

  • Add Laemmli buffer and heat at 95°C for 5 minutes immediately before SDS-PAGE

• Immunoprecipitation Enhancement:

  • For low abundance proteins, immunoprecipitate total JAK2 first

  • Wash immunoprecipitates 3-4 times with lysis buffer containing phosphatase inhibitors

  • Elute and analyze by western blotting with phospho-specific antibody

These methods have been validated in published studies demonstrating successful detection of Y119 phosphorylation in response to cytokine stimulation .

What are the best approaches for validating the specificity of Phospho-JAK2 (Y119) antibody detection?

Rigorous validation is essential for phospho-specific antibodies:

• Genetic approaches:

  • Express Y119F mutant as negative control

  • Use JAK2-deficient cells reconstituted with wild-type or mutant JAK2

  • Compare kinase-active vs. kinase-dead (K882R) JAK2 to confirm kinase-dependency

• Peptide competition assays:

  • Pre-incubate antibody with phosphorylated Y119 peptide (should block signal)

  • Pre-incubate with non-phosphorylated Y119 peptide (should not affect signal)

  • Use titration of competing peptide to determine specificity threshold

• Pharmacological approaches:

  • Treat cells with JAK inhibitors (e.g., ruxolitinib) to prevent phosphorylation

  • Use phosphatase treatment of lysates to remove phosphorylation

  • Compare multiple stimulation conditions known to induce or not induce Y119 phosphorylation

• Cross-platform validation:

  • Confirm phosphorylation by mass spectrometry

  • Use multiple antibodies from different sources when available

  • Correlate functional outcomes with phosphorylation status

Research has demonstrated that a properly validated phospho-Y119 antibody should show: stimulation-dependent signal, absence of signal with Y119F mutant, dependency on JAK2 kinase activity, and blockade by phosphopeptide but not non-phosphopeptide competition .

How does the role of Y119 phosphorylation differ across various cytokine receptor systems?

Y119 phosphorylation exhibits intriguing receptor-specific effects that provide insight into differential regulation of cytokine signaling:

These receptor-specific differences suggest:

• Structural determinants: Different cytokine receptor families likely have unique structural features that interact differently with the JAK2 FERM domain containing Y119.

• Signaling complex composition: Auxiliary proteins present in different receptor complexes may influence how Y119 phosphorylation affects JAK2-receptor interactions.

• Regulatory mechanisms: The IFN-γ receptor system may employ alternative mechanisms to regulate signal duration that do not depend on Y119 phosphorylation.

For researchers interested in receptor specificity, JAK2-deficient cell systems reconstituted with wild-type or mutant JAK2 provide a powerful platform for comparative analysis across multiple receptor systems .

What are the implications of Y119 phosphorylation for JAK2-targeted therapeutics in myeloproliferative neoplasms?

Understanding Y119 phosphorylation offers several potential implications for therapeutic approaches:

• Novel inhibitor design strategies:

  • Current JAK2 inhibitors primarily target the ATP-binding pocket in the kinase domain

  • Y119-focused approaches could target the FERM domain to modulate receptor interactions

  • Small molecules or peptides that mimic phosphorylated Y119 might disrupt JAK2-receptor interactions

• Biomarker potential:

  • Y119 phosphorylation status might serve as a biomarker for JAK2 inhibitor efficacy

  • Differential Y119 phosphorylation patterns could help stratify patients with JAK2-dependent malignancies

  • Monitoring could help predict resistance mechanisms

• Receptor-selective targeting:

  • The differential effects of Y119 across receptor systems suggest possibilities for receptor-selective intervention

  • This could potentially reduce off-target effects compared to kinase domain inhibitors

  • Particularly relevant for conditions where specific cytokine pathways drive pathology

• Combination therapy rationale:

  • Understanding Y119 regulation might reveal synergistic approaches

  • Combining kinase domain inhibitors with agents affecting receptor-JAK2 interactions could enhance efficacy

JAK2 is a key target for myeloproliferative neoplasm (MPN) treatment, with inhibiting the JAK2-STAT signaling pathway being a prominent research direction . Y119 phosphorylation represents an underexplored regulatory mechanism that might complement existing therapeutic strategies.

How might advanced techniques like phosphoproteomics and structural biology further elucidate the role of Y119 phosphorylation?

Cutting-edge technologies offer opportunities to deepen our understanding of Y119 function:

• Quantitative phosphoproteomics approaches:

  • Temporal mapping of multiple JAK2 phosphorylation sites simultaneously

  • Identification of proteins that differentially associate with JAK2 based on Y119 phosphorylation status

  • Comparison of phosphorylation networks downstream of wild-type vs. Y119 mutant JAK2

• Structural biology techniques:

  • Cryo-electron microscopy of JAK2-receptor complexes with and without Y119 phosphorylation

  • X-ray crystallography of FERM domain with phosphorylated vs. non-phosphorylated Y119

  • NMR studies to detect conformational changes induced by Y119 phosphorylation

  • Hydrogen-deuterium exchange mass spectrometry to map structural dynamics

• Advanced cellular imaging:

  • FRET/FLIM approaches to monitor JAK2-receptor association dynamics in live cells

  • Super-resolution microscopy to visualize receptor complex formation/dissociation

  • Single-molecule tracking to measure kinetics of JAK2-receptor interactions

• Systems biology integration:

  • Mathematical modeling of JAK2 signaling incorporating Y119 phosphorylation

  • Network analysis to identify key nodes influenced by Y119 status

  • Machine learning approaches to predict functional outcomes of Y119 modification

These advanced approaches could resolve outstanding questions about the precise mechanical role of Y119 phosphorylation in JAK2 function, potentially revealing new therapeutic opportunities for conditions involving dysregulated cytokine signaling.